Abstract:ID 92437 Poster Board 500 Opioid drugs (e.g., morphine) are used medicinally for pain-relief but can also produce adverse effects such as constipation. Further, patients diagnosed with obesity often experience pain-related conditions and are prescribed opioids for pain management. Eating a diet that is high in fat and carbohydrates can lead to obesity; however, it is not known if the therapeutic or adverse effects of morphine are impacted by dietary manipulation. To explore this, the effects of acute morphine administration were assessed in male and female Sprague-Dawley rats ( n = 8/dietary group) eating a standard (low fat) laboratory chow (17% kcal from fat), a high fat/high carbohydrate chow (60% kcal from fat), or a ketogenic (high fat/low carbohydrate) chow (90.5% kcal from fat). Morphine-induced antinociception was assessed using the warm water tail withdrawal procedure (0.32 – 17.8 mg/kg IP) in both sexes. Additionally, fecal motility was assessed by counting and weighing fecal output hourly, following an injection of saline or morphine (1, 3.2, or 10 mg/kg IP) for male rats eating wet homogenized chows ( n = 2-3/dietary group). It was hypothesized that rats eating high fat chow would be more sensitive to the antinociceptive effects of morphine as compared to rats eating standard or ketogenic chow. It was further hypothesized that rats eating high fat chow would be more sensitive to the impact of morphine on gastrointestinal transit than rats eating other diets. Warm water tail withdrawal latencies were converted to a % of the maximum possible effect and were averaged by each dietary group. Mixed model ANOVAs revealed that there were no diet- or sex-related differences in morphine-induced anticonception. While fecal output was generally greater for rats eating standard chow as compared to rats eating other diets, morphine consistently decreased fecal output for rats in all dietary conditions. However, this effect was only significant following the largest dose of morphine (10 mg/kg) for rats eating standard chow, whereas all doses of morphine significantly decreased fecal output for rats eating the high fat/high carbohydrate chow or the ketogenic chow. These results suggest that while the therapeutic effects of morphine are consistent regardless of dietary intake in both sexes, dietary intake might impact individual susceptibility to the effects of morphine on gastrointestinal transit. Future studies are under way to assess the impact of diet on morphine-induced changes to fecal output in female rats, along with other effects of morphine including the rewarding effects, tolerance, and withdrawal. K.M.S., was supported by the NIDA of the NIH under award R25DA033613, and by a NIDA RCMI supplement under award 3U54MD007592-29S4, and experiments were funded through NIGMS of the NIH under award R16 GM149426-01.

Oral Morphine Pharmacokinetic in Obesity: The Role of P-Glycoprotein, MRP2, MRP3, UGT2B7, and CYP3A4 Jejunal Contents and Obesity-Associated Biomarkers

Influence of UGT2B7, OPRM1 and ABCB1 gene polymorphisms on postoperative morphine consumption

Lack of genetic association between OCT1, ABCB1, and UGT2B7 variants and morphine pharmacokinetics

Design, Synthesis, and Biological Evaluation of 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan Derivatives As Peripheral Selective Μ Opioid Receptor Agents.

Morphine-Induced Antinociception and Fecal Motility in Rats Eating a High Fat/High Carbohydrate or Ketogenic Diet

Association of CYP2D6 genotype predicted phenotypes with oxycodone requirements and side effects in children undergoing surgery

Pharmacokinetic and neuroimmune pharmacogenetic impacts on slow-release morphine cancer pain control and adverse effects

ABCB1 genetic polymorphisms affect opioid requirement by altering function of the intestinal P-glycoprotein

Influence of OCT1 Ontogeny and Genetic Variation on Morphine Disposition in Critically Ill Neonates: Lessons From PBPK Modeling and Clinical Study

Impact of pharmacogenomic profiles on post-surgical pain following laparotomy for gynecologic pathology

Altered morphine glucuronide and bile acid disposition in patients with nonalcoholic steatohepatitis

Population Pharmacokinetics of Morphine in Patients With Nonalcoholic Steatohepatitis (NASH) and Healthy Adults

Effect of opioid-free versus opioid-based strategies during multimodal anaesthesia on postoperative morphine consumption after bariatric surgery: a randomised double-blind clinical trial

Pharmacogenomics and Morphine

Exploring the Impact of CYP2D6 and UGT2B7 Gene-Drug Interactions, and CYP-mediated DDI on Oxycodone and Oxymorphone Pharmacokinetics using Physiologically-Based Pharmacokinetic Modelling and Simulation

Pooled Analysis of Gastric Emptying in Patients With Obesity: Implications for Oral Absorption Projection

17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-(4'-pyridylcarboxamido)morphinan (NAP) Modulating the Mu Opioid Receptor in a Biased Fashion.

Impacts of genetic polymorphisms and cancer cachexia on naldemedine pharmacokinetics and bowel movements in patients receiving opioid analgesics

Identification of Preoperative Serum Metabolites Associated with Postoperative Opioid Consumption in Gastric Cancer Patients by Extreme Phenotype Sampling.

Morphine induces changes in the gut microbiome and metabolome in a morphine dependence model

The Regioselective Glucuronidation of Morphine by Dimerized Human UGT2B7, 1A1, 1A9 and Their Allelic Variants